Explore 3 Stock Ideas & Industry Insights Download Free Report

Curvebeam Ai Ltd

Company price
0.018 AUD 0.00(0%)
Last update at 2026-11-11T23:00:00Z
VOLUME
471452
Market Cap
6.59M

Momentum Score

…

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.02
Low
0.02
High
52 Week Price Range
0.01
Low
0.10
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Public information on Curvebeam Ai Ltd (ASX: CVB) is limited and does not clearly document the company's core business or long-term growth drivers. Investors should monitor official filings and announcements for strategy and financials; any prospective upside depends on execution of an unverified business plan and broader market conditions.

Key investment risks include limited transparency, potentially low liquidity, execution and financial uncertainty arising from sparse public disclosures.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.02
Dividend Yield
-
Revenue TTM
8.67M
Revenue Per Share
0.02
Gross Profit TTM
2.81M
Debt / Equity
-
ROE
-59.88%
Net Debt
14.52M
ROCE
-39.84%
Diluted EPS TTM
-0.04

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Income before tax -18.83M -16.84M -23.10M -51.23M -9.62M
Net income -18.83M -16.84M -23.10M -51.23M -9.62M
Selling general administrative 15.04M 20.73M 18.02M 12.98M 9.37M
Gross profit 2.85M 5.43M 3.01M 4.39M 3.99M
Reconciled depreciation 3.13M - 2.83M 1.98M 0.46M
Ebit -18.00M - - - -
Ebitda -14.87M - - - -
Operating income -20.39M -16.84M -23.94M -18.76M -11.99M
Interest expense 0.83M 0.21M 1.64M 5.73M 0.12M
Tax provision 0.00M 0.00M 0.00M 0.00M 0.00M
Interest income 0.11M - 0.37M 0.04M -
Net interest income -0.73M - -1.27M -5.69M -0.12M
Total revenue 8.67M 12.10M 6.53M 8.06M 7.42M
Total operating expenses - 28.94M - - -
Cost of revenue 5.82M 6.67M 3.52M 3.66M 3.43M
Total other income expense net 2.29M - 2.11M -26.78M 2.50M
Net income from continuing ops -18.83M - -23.10M -51.23M -9.62M
Net income applicable to common shares - -16.84M - - -
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total assets 53.23M 60.98M 63.33M 61.36M 0.00M
Intangible assets 13.92M 16.43M 18.16M 20.54M -
Other current assets 0.03M - 0.04M 0.16M -
Total liab 25.44M 25.87M 24.41M 109.46M 0.00M
Total stockholder equity 27.78M 35.11M 38.92M -48.10M 0.00M
Other current liab 2.83M - 2.73M 31.15M -
Common stock - 136.65M - - -
Capital stock 147.12M - 125.10M 17.36M -
Retained earnings -126.58M -102.76M -92.39M -69.31M -
Good will 20.18M 20.18M 20.18M 20.18M -
Other assets - 0.15M - - -
Cash 1.64M - 6.45M 5.16M -
Cash and equivalents - 5.04M - - -
Total current liabilities 8.05M 8.21M 8.17M 38.81M 0.00M
Net debt 14.52M - 8.64M 8.56M -
Short term debt - 1.03M - - -
Short long term debt 1.36M - 1.10M 1.07M -
Other stockholder equity - 1.22M - - -
Property plant equipment - 2.64M - - -
Total current assets 14.90M 20.26M 23.36M 19.48M 0.00M
Long term investments - - 0.15M 0.02M -
Net receivables 0.35M 0.53M 2.04M 2.70M -
Long term debt 14.80M 14.49M 13.99M 12.64M -
Inventory 9.74M 10.26M 10.76M 8.66M -
Accounts payable 1.15M - 1.93M 2.42M -
Non currrent assets other 0.15M - - - -
Non current assets total 38.33M - 39.97M 41.89M 0.00M
Capital lease obligations 1.49M - 0.84M 1.13M -
Long term debt total - 16.02M - - -
Breakdown 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2026-06-30 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investments - - -0.32M -4.10M -0.31M
Total cashflows from investing activities - -0.49M - - -
Net borrowings 0.26M - - - -
Total cash from financing activities 9.76M 10.31M 23.63M 22.25M 20.06M
Net income -18.83M - -23.10M -51.23M -9.62M
Change in cash -3.27M -1.41M 1.45M -3.52M 9.56M
Begin period cash flow 5.04M - 5.16M 8.70M 0.26M
End period cash flow 1.64M - 6.45M 5.16M 10.10M
Total cash from operating activities - -11.17M - - -
Issuance of capital stock 10.50M - 24.98M 23.40M 2.10M
Sale purchase of stock -0.68M 11.58M -1.81M -0.14M -
Other cashflows from financing activities - -1.04M - - -
Capital expenditures 0.02M 0.49M 0.32M 0.84M 0.31M
Change in working capital - 0.23M - - -
Free cash flow -13.03M - -22.18M -22.52M -10.50M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(AUD)
Price
(AUD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
CVB
Curvebeam Ai Ltd
-
-%
0.02 - - 0.76 0.50 3.45
COH
Cochlear Ltd
2.26
1.50%
152.98 68.64 27.40 4.30 5.34 3.97
IMR
Imricor Medical Systems Inc
0.06
4.72%
1.33 - - 36401.21 17.45 4019.33
AVR
Anteris Technologies Global Corp
0.50
5.88%
9.00 - - 356.02 2.19 130.34
AVH
Avita Medical Inc
-0.11
2.13%
5.06 - 9.97 9.59 7.17 6.76

Profile*

Curvebeam Ai Ltd

CurveBeam AI Limited engages in the development and manufacture of point-of care specialized weight bearing medical imaging equipment in Europe, North America, and internationally. The company offers HiRise for bilateral weight bearing CT imaging; LineUP, a bilateral, weight bearing CT imaging of the knees and lower extremities for orthpedic practices; pedCAT Premium and pedCAT for imaging of the foot and ankle; InReach, a point-of-care extremity CT imaging which assess the distal extremities with 3D clarity at a fraction of the dose; and CubeVue Software visualization tools. It also provides software CurveBeam AI Autometrics for automatically segment foot and ankle datasets; Axiometrics, provides a semi-automatic measurement of the axes of rotation of the hip, femur, knee, and ankle; and TALAS, a measurement tool that semi-automatically calculate hindfoot alignment based on reproducible three-dimensional anatomical landmarks. In addition, the company offers custom web-based cloud platform; and OSSView. The company was incorporated in 2009 and is headquartered in Hatfield, Pennsylvania.

2800 Bronze Drive, Hatfield, PA, United States, 19440

267 483 8081

Name Title Year Born
Mr. Gregory Brown BSc, MBA CEO, MD & Director 1964
Mr. Gregory Brown BSc, MBA CEO, MD & Director 1964
Mr. Gregory Brown BSc, MBA CEO, MD & Director 1964
Dr. Aloys Mbala Co-Founder NA
Mr. Ali Ghasemzadeh Co-Founder NA
Mr. Ura Phillip Stephen Auckland CFO & Company Secretary NA
Mr. Arun Bahadur Singh COO, CTO (CT), President of US & Europe Division and Executive Director 1959
Mr. S. Turner Dean Chief Sales Officer NA
Ms. Vinti Singh Vice President of Marketing NA
Dr. Yu Peng B.S., Ph.D. Chief Technology Officer (AI) NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…